What is left ventricular hypertrophy and is there a reason to regress left ventricular hypertrophy?
作者信息
Weir Matthew R, Townsend Raymond R
机构信息
Division of Nephrology, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD 21202, USA.
出版信息
J Clin Hypertens (Greenwich). 2009 Aug;11(8):407-10. doi: 10.1111/j.1751-7176.2009.00156.x.
Abstract
摘要
相似文献
1
What is left ventricular hypertrophy and is there a reason to regress left ventricular hypertrophy?
J Clin Hypertens (Greenwich). 2009 Aug;11(8):407-10. doi: 10.1111/j.1751-7176.2009.00156.x.
2
Ventricular dysrhythmias, left ventricular hypertrophy, and sudden death.
Cardiovasc Drugs Ther. 1994 Aug;8 Suppl 3:557-63. doi: 10.1007/BF00877224.
3
Left ventricular hypertrophy and heart failure in women.
J Hypertens Suppl. 2002 May;20(2):S34-8.
4
[Ventricular arrhythmia and sudden cardiac death: the significance of left ventricular hypertrophy as risk factor].
Schweiz Med Wochenschr. 1993 Jan 30;123(4):99-107.
5
Left ventricular hypertrophy: reduction of blood pressure already in the normal range further regresses left ventricular mass.
Heart. 2010 Jan;96(2):148-52. doi: 10.1136/hrt.2009.177238. Epub 2009 Oct 26.
6
7
Hypertensive heart disease, ventricular dysrhythmias, and sudden death.
Adv Exp Med Biol. 1997;432:263-72. doi: 10.1007/978-1-4615-5385-4_28.
8
Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death: the LIFE Study.
Circulation. 2007 Aug 14;116(7):700-5. doi: 10.1161/CIRCULATIONAHA.106.666594. Epub 2007 Jul 30.
9
Association of heart failure hospitalizations with combined electrocardiography and echocardiography criteria for left ventricular hypertrophy.
Am J Hypertens. 2012 Jun;25(6):678-83. doi: 10.1038/ajh.2012.31. Epub 2012 Mar 29.
10
Physical Exercise Combined with Antihypertensive Drug Therapy on Left Ventricular Hypertrophy: Systematic Review and Meta-Analysis.
High Blood Press Cardiovasc Prev. 2020 Dec;27(6):493-503. doi: 10.1007/s40292-020-00403-z. Epub 2020 Aug 10.
引用本文的文献
1
Screening for Left Ventricular Hypertrophy Using Artificial Intelligence Algorithms Based on 12 Leads of the Electrocardiogram-Applicable in Clinical Practice?-Critical Literature Review with Meta-Analysis.
Healthcare (Basel). 2025 Feb 14;13(4):408. doi: 10.3390/healthcare13040408.
2
Hydrochlorothiazide vs chlorthalidone, indapamide, and potassium-sparing/hydrochlorothiazide diuretics for reducing left ventricular hypertrophy: A systematic review and meta-analysis.
J Clin Hypertens (Greenwich). 2018 Oct;20(10):1507-1515. doi: 10.1111/jch.13386. Epub 2018 Sep 24.
本文引用的文献
1
Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.
N Engl J Med. 2008 Dec 4;359(23):2417-28. doi: 10.1056/NEJMoa0806182.
2
Importance of arterial stiffness as cardiovascular risk factor for future development of new type of drugs.
Fundam Clin Pharmacol. 2008 Jun;22(3):241-6. doi: 10.1111/j.1472-8206.2008.00584.x.
3
Central pressure: variability and impact of cardiovascular risk factors: the Anglo-Cardiff Collaborative Trial II.
Hypertension. 2008 Jun;51(6):1476-82. doi: 10.1161/HYPERTENSIONAHA.107.105445. Epub 2008 Apr 21.
4
Mechanical factors in arterial aging: a clinical perspective.
J Am Coll Cardiol. 2007 Jul 3;50(1):1-13. doi: 10.1016/j.jacc.2006.12.050. Epub 2007 Jun 18.
5
Analyzing the radial pulse waveform: narrowing the gap between blood pressure and outcomes.
Curr Opin Nephrol Hypertens. 2007 May;16(3):261-6. doi: 10.1097/MNH.0b013e328042baa4.
6
Expert consensus document on arterial stiffness: methodological issues and clinical applications.
Eur Heart J. 2006 Nov;27(21):2588-605. doi: 10.1093/eurheartj/ehl254. Epub 2006 Sep 25.
7
Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.
Circulation. 2006 Mar 7;113(9):1213-25. doi: 10.1161/CIRCULATIONAHA.105.595496. Epub 2006 Feb 13.
8
Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy.
Hypertension. 2005 Jul;46(1):200-4. doi: 10.1161/01.HYP.0000168052.00426.65. Epub 2005 May 23.
9
Role of arterial wall properties in the pathogenesis of systolic hypertension.
Am J Hypertens. 2005 Jan;18(1 Pt 2):19S-22S. doi: 10.1016/j.amjhyper.2004.10.001.
10
Increased left ventricular mass is a risk factor for the development of a depressed left ventricular ejection fraction within five years: the Cardiovascular Health Study.
J Am Coll Cardiol. 2004 Jun 16;43(12):2207-15. doi: 10.1016/j.jacc.2003.11.064.
Zotero 插件